HCBD-Pro Services
Client Subscribers
HIPN Daily Archive
No Password Required
HIPN Daily SignUp
free e-newsletter
No Password Required
Current Headlines
No Password Required
Events Calendar
No Password Required
HCBD-PRO Services
Search Companies
Search People
Search News|Events
Query News -
By Companies
By People
HR Announcements
Health Plan Industry
MailingList Rental
HCBD-EmailSend
Broadcast Email
HCBD Journalist Wire
News Distribution
Website | e-newsletter
Online Advertising
Trade Conf | Webinar
Event Promotion
Welcome <Guest>
Login
back to News
McKesson Specialty Health: KISQALI (ribociclib) Approved for the Treatment of HR+/HER2- Advanced Breast Cancer, available for order at Biologics, Inc.
Source
McKesson Specialty Health | US Oncology
Published Date
3/20/2017
Biologics, Inc., a McKesson Specialty Health oncology pharmacy services company, has been selected by Novartis to be a specialty pharmacy provider for KISQALI® (ribociclib). ...
View the entire McKesson Specialty Health | US Oncology article
LinkedIn
Featured Companies
McKesson Specialty Health | US Oncology
The Woodlands, TX
Company Representatives Featured
Claire Crye
[Media Relations Manager]
McKesson Specialty Health | US Oncology
Media Contact
Joyce O'Shaughnessy
[Medical Oncologist]
Texas Oncology
Brandon Tom
[Senior Director of Oral Oncolytic Services]
McKesson Specialty Health | US Oncology
back to News
About Us
|
Purchase Pro
|
Contact Us
© 2006-2010 Healthcare BizDev, Inc. All rights reserved.
Privacy Policy
|
Legal Conditions